Exponent Inc (EXPO)

Currency in USD
67.10
-1.11(-1.63%)
Closed·
67.100.00(0.00%)
·
Advertisement
EXPO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
66.9068.50
52 wk Range
51.9181.95
Key Statistics
Prev. Close
68.21
Open
68.41
Day's Range
66.9-68.5
52 wk Range
51.91-81.95
Volume
263.61K
Average Volume (3m)
579.73K
1-Year Change
-3.1047%
Book Value / Share
5.95
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EXPO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
84.00
Upside
+25.19%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Exponent Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 84.00
(+25.19% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Hold72.00+7.30%75.00Maintain31/07/2026
JPMorgan
Buy90.00+34.13%80.00Maintain31/07/2026
UBS
Hold75.00+11.77%75.00Maintain02/06/2026
JPMorgan
Buy80.00+19.23%95.00Maintain15/05/2026
UBS
Hold75.00+11.77%85.00Maintain01/05/2026

Exponent Inc Earnings Call Summary for Q2/2026

  • Exponent beat Q2 2026 estimates with EPS of $0.60 vs. $0.55 expected and revenue of $171.6M, 19% above forecasts driven by AI user research.
  • Company raised full-year net revenue growth guidance to 9%-10% with EBITDA margins of 27.8%-28.1%; Q3 net revenue expected up 8%-10%.
  • EBITDA margin expanded to 28.7% from 27.8% year-over-year, reflecting improved operating leverage and 74% utilization rate.
  • Board authorized additional $50M stock repurchase; company bought back $211M over past 12 months, reducing shares outstanding to 49M from 51.5M.
  • AI-enabled product testing and user research emerged as key growth driver, with management noting expansion into physical products and systems.
Last Updated: 30/07/2026, 22:30
Read Full Transcript

Earnings

Latest Release
30/07/2026
EPS / Forecast
0.60 / 0.55
Revenue / Forecast
171.61M / 144.07M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.23%
Dividend Yield
1.85%
Industry Median 1.35%
Annualised payout
1.24
Paid quarterly
5-Years Growth
+9.36%
Growth Streak

Compare EXPO to Peers and Sector

Metrics to compare
EXPO
Peers
Sector
Relationship
P/E Ratio
28.5x28.3x12.1x
PEG Ratio
2.39−1.110.03
Price/Book
11.1x2.5x1.4x
Price / LTM Sales
5.6x1.2x1.2x
Upside (Analyst Target)
34.1%17.3%25.0%
Fair Value Upside
Unlock19.8%7.4%Unlock

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
24.32M50.13%1.63B
Other Institutional Investors
22.70M46.79%1.52B
Public Companies & Retail Investors
1.49M3.08%100.27M
Total
48.51M100.00%3.26B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.13.01%6,184,950415,010
Kayne Anderson Rudnick Investment Management, LLC8.17%3,886,546260,787

People Also Watch

125.85
FSS
+2.27%
19.62
UPBD
-0.25%
83.24
BCC
-1.06%
6.79
OI
-0.73%
90.72
CWST
-0.34%

FAQ

What Is the Exponent (NASDAQ: EXPO) Share Price Today?

The Exponent stock price today is 67.10 USD.

What Stock Exchange Does Exponent (EXPO) Trade On?

Exponent is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Exponent?

The stock symbol (also called a 'ticker') for Exponent is "EXPO."

Does Exponent Pay Dividends? What’s The Current EXPO Dividend Yield?

Yes, EXPO Pays Dividends to its Shareholders. The current Exponent dividend yield is 1.85%.

What Is the Current Exponent Market Capitalisation?

As of today, Exponent (NASDAQ: EXPO) market cap is 3.19B USD.

What Is Exponent's (EXPO) Earnings Per Share (TTM)?

The Exponent EPS is currently 2.23 (Trailing Twelve Months).

When Is the Next Exponent Earnings Date?

Exponent's next earnings report will be released on 22/10/2026.

Is EXPO a Buy or Sell From a Technical Analyst Perspective?

Based on today's Exponent moving averages and other technical indicators, the daily buy/sell signal for EXPO stock is Strong Buy.

How Many Times Has Exponent Stock Split?

Exponent has split 3 times. (See the EXPO stock split history page for full effective split date and price information.)

How Many Employees Does Exponent Have?

Exponent has 1012 employees, based on their latest Companies House report.

What is the current trading status of Exponent (NASDAQ: EXPO)?

As of 16/08/2026, Exponent (EXPO) is trading at a share price of 67.10 USD, with a previous close of 68.21 USD. The stock has fluctuated within a day range of 66.90 USD to 68.50 USD, while its 52-week range spans from 51.91 USD to 81.95 USD.

What Is Exponent (EXPO) Price Target According to Analysts?

The average 12-month price target for Exponent is 84.00 USD, with a high estimate of 90 USD and a low estimate of 72 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +25.19% Upside potential.

What Is the EXPO Premarket Price?

EXPO's last pre-market stock price is 67.89 USD. The pre-market share volume is 20.00, and the stock has decreased by -0.32, or -0.47%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.